Utah Medical Products, Inc. (UTMD) Director Sells $681,396.50 in Stock

Utah Medical Products, Inc. (NASDAQ:UTMD) Director Ernst G. Hoyer sold 6,550 shares of Utah Medical Products stock in a transaction dated Friday, May 18th. The shares were sold at an average price of $104.03, for a total value of $681,396.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Utah Medical Products traded up $0.35, hitting $105.05, on Thursday, Marketbeat.com reports. 22,500 shares of the company’s stock traded hands, compared to its average volume of 14,739. Utah Medical Products, Inc. has a 1 year low of $68.10 and a 1 year high of $109.65. The stock has a market cap of $391.71 million, a PE ratio of 25.93 and a beta of 0.60.

Utah Medical Products (NASDAQ:UTMD) last released its earnings results on Thursday, April 26th. The medical instruments supplier reported $1.09 earnings per share for the quarter. Utah Medical Products had a return on equity of 18.94% and a net margin of 21.56%. The company had revenue of $10.89 million for the quarter.

The company also recently declared a dividend, which was paid on Thursday, June 7th. Stockholders of record on Friday, June 15th were issued a dividend of $0.27 per share. The ex-dividend date of this dividend was Thursday, June 14th.

Several equities analysts have weighed in on UTMD shares. BidaskClub cut Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, April 4th. ValuEngine raised Utah Medical Products from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd.

Several institutional investors have recently made changes to their positions in UTMD. Renaissance Technologies LLC lifted its holdings in shares of Utah Medical Products by 9.8% during the 4th quarter. Renaissance Technologies LLC now owns 212,200 shares of the medical instruments supplier’s stock valued at $17,273,000 after buying an additional 18,900 shares during the last quarter. Bailard Inc. acquired a new stake in shares of Utah Medical Products during the 4th quarter valued at about $816,000. Ancora Advisors LLC lifted its holdings in shares of Utah Medical Products by 13.1% during the 1st quarter. Ancora Advisors LLC now owns 79,587 shares of the medical instruments supplier’s stock valued at $7,867,000 after buying an additional 9,229 shares during the last quarter. Russell Investments Group Ltd. lifted its holdings in shares of Utah Medical Products by 10.3% during the 1st quarter. Russell Investments Group Ltd. now owns 78,528 shares of the medical instruments supplier’s stock valued at $7,763,000 after buying an additional 7,350 shares during the last quarter. Finally, Deutsche Bank AG lifted its holdings in shares of Utah Medical Products by 39.7% during the 4th quarter. Deutsche Bank AG now owns 24,659 shares of the medical instruments supplier’s stock valued at $2,005,000 after buying an additional 7,002 shares during the last quarter. Institutional investors and hedge funds own 69.26% of the company’s stock.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.

Insider Buying and Selling by Quarter for Utah Medical Products (NASDAQ:UTMD)

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply